It is administered intravenously to patients who are unable to take oral potassium supplements or when a rapid replacement of ...

Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The OVERWRAP label of lot 1030613, Expiration Date: 09 ...

The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled lot of 20 mEq potassium chloride ...

Adopting lethal injection in India would create deep ethical and practical conflicts for doctors, erode public trust in ...

The FDA and CDC, in collaboration with the Infant Botulism Treatment and Prevention Program (IBTPP), and state and local partners, are investigating a multistate outbreak of 13 infant botulism ...

He regrets he did not take better care of his health, even after he was diagnosed with diabetes 10 years ago. Read more at straitstimes.com. Read more at straitstimes.com.

TransMedics Group, Inc. ("TransMedics") , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on ...

Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management and business ...

SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial SPVN20 aims to restore visual ...

A rarer condition that causes eye twitching is known as blepharospasm and involves “forceful, involuntary closure of both eyes at the same time,” Moss says. She notes that blepharospasm can range from ...

Oklahoma City bomber Timothy McVeigh, who killed 168 people in the nation's worst act of domestic terrorism, was put to death by lethal injection at 8:14 a.m. ET Monday. McVeigh, who never showed any ...

SparingVision has dosed the first patient in its NYRVANA clinical trial of SPVN20 in patients with advanced retinitis ...